cox proportional hazards (ph) model regression sas proc phreg (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
cox proportional hazards (ph) model regression sas proc phreg
Cox Proportional Hazards (Ph) Model Regression Sas Proc Phreg, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cox+proportional+hazards+(ph)+model+regression+sas+proc+phreg/cox+proportional+hazards+models+sas+proc+phreg/pm23996086-42-0-6
Average 90 stars, based on 1 article reviews
Cox Proportional Hazards (Ph) Model Regression Sas Proc Phreg, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cox+proportional+hazards+(ph)+model+regression+sas+proc+phreg/cox+proportional+hazards+models+sas+proc+phreg/pm23996086-42-0-6
Average 90 stars, based on 1 article reviews
cox proportional hazards (ph) model regression sas proc phreg - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Biomarker Discovery:Article Title: Factors associated with the occurrence and treatment of supraventricular tachycardia in a pediatric congenital heart disease cohort. Article Snippet: In patients with congenital heart disease (CHD), the association between supraventricular tachycardia (SVT), type of pathophysiology, and therapeutic interventions in a population-based cohort warrants further examination.. A retrospective, longitudinal 15-year data set (1996–2010) was analyzed.. Inclusion criteria included age B17 years, enrolled in South Carolina State Medicaid, and diagnosed as having one or more CHDs as well as SVT. Article Title: Neuroendocrine‐Related Adverse Events Associated with Antidepressant Treatment in Children and Adolescents Article Snippet: A Article Title: Cardiovascular and neurological adverse events associated with antidepressant treatment in children and adolescents. Article Snippet: A retrospective cohort design of Medicaid medical and pharmacy claims for 1996 through 2005 was employed for 14 171 children and adolescents prescribed an antidepressant medication and a random sample of 4500 children not treated with any class of psychotropic medication to compare the prevalence rates of cardiovascular and neurological adverse events.. The treated cohort evinced a higher prevalence of cardiovascular events, orthostatic hypotension, seizures, insomnia, and headaches.. In the treated cohort, patients were at a significantly higher risk for incident cardiovascular events when exposed to selective serotonin reuptake inhibitors and weight-inducing antidepressants, mood stabilizers, and antipsychotics. Medications:Article Title: Factors associated with the occurrence and treatment of supraventricular tachycardia in a pediatric congenital heart disease cohort. Article Snippet: In patients with congenital heart disease (CHD), the association between supraventricular tachycardia (SVT), type of pathophysiology, and therapeutic interventions in a population-based cohort warrants further examination.. A retrospective, longitudinal 15-year data set (1996–2010) was analyzed.. Inclusion criteria included age B17 years, enrolled in South Carolina State Medicaid, and diagnosed as having one or more CHDs as well as SVT. Article Title: Neuroendocrine‐Related Adverse Events Associated with Antidepressant Treatment in Children and Adolescents Article Snippet: A Article Title: Cardiovascular and neurological adverse events associated with antidepressant treatment in children and adolescents. Article Snippet: A retrospective cohort design of Medicaid medical and pharmacy claims for 1996 through 2005 was employed for 14 171 children and adolescents prescribed an antidepressant medication and a random sample of 4500 children not treated with any class of psychotropic medication to compare the prevalence rates of cardiovascular and neurological adverse events.. The treated cohort evinced a higher prevalence of cardiovascular events, orthostatic hypotension, seizures, insomnia, and headaches.. In the treated cohort, patients were at a significantly higher risk for incident cardiovascular events when exposed to selective serotonin reuptake inhibitors and weight-inducing antidepressants, mood stabilizers, and antipsychotics. Control:Article Title: Factors associated with the occurrence and treatment of supraventricular tachycardia in a pediatric congenital heart disease cohort. Article Snippet: In patients with congenital heart disease (CHD), the association between supraventricular tachycardia (SVT), type of pathophysiology, and therapeutic interventions in a population-based cohort warrants further examination.. A retrospective, longitudinal 15-year data set (1996–2010) was analyzed.. Inclusion criteria included age B17 years, enrolled in South Carolina State Medicaid, and diagnosed as having one or more CHDs as well as SVT. Article Title: Neuroendocrine‐Related Adverse Events Associated with Antidepressant Treatment in Children and Adolescents Article Snippet: A Article Title: Cardiovascular and neurological adverse events associated with antidepressant treatment in children and adolescents. Article Snippet: A retrospective cohort design of Medicaid medical and pharmacy claims for 1996 through 2005 was employed for 14 171 children and adolescents prescribed an antidepressant medication and a random sample of 4500 children not treated with any class of psychotropic medication to compare the prevalence rates of cardiovascular and neurological adverse events.. The treated cohort evinced a higher prevalence of cardiovascular events, orthostatic hypotension, seizures, insomnia, and headaches.. In the treated cohort, patients were at a significantly higher risk for incident cardiovascular events when exposed to selective serotonin reuptake inhibitors and weight-inducing antidepressants, mood stabilizers, and antipsychotics. |